Ginkgo Bioworks

Ginkgo Bioworks, Inc. is a synthetic biology company founded in 2008 by a team of MIT scientists. Based in Boston, the company specializes in programming cells through genetic engineering to tackle challenges in various industries, including agriculture, pharmaceuticals, chemicals, and food. Ginkgo's mission is to simplify the engineering of biology, similar to how computers are programmed. The company operates a cell programming platform that allows customers to design, modify, and optimize microorganisms for specific biological functions, such as producing enzymes and therapeutics. Ginkgo has also played a role in biosecurity, providing testing and support during the COVID-19 pandemic. With large-scale facilities in Boston, Ginkgo continues to expand its capabilities through strategic acquisitions and partnerships, targeting diverse sectors for sustainable solutions and innovative products.